He ridiculed them for the more than 40 votes theyve taken to repeal his health care proposal as a waste of time and energy. Now theyve gone beyond just holding Congress hostage. Theyre holding the whole country hostage, with the key deadlines looming, Obama said. Obama was speaking at a Ford Motor Co. stamping plant near Kansas City, and he told the workers that the shutdown will hurt Americans like them.
For the original version including any supplementary images or video, visit http://www.washingtonpost.com/politics/congress/his-leverage-maxed-out-obama-regroups-for-fiscal-battles-with-congress-at-missouri-auto-plant/2013/09/20/ba096dfa-21c8-11e3-ad1a-1a919f2ed890_story.html
5 Health Care Companies That Should Raise Their Dividends
Foes of the Affordable Care Act have run nearly five times the number of TV commercials in recent months as its proponents have aired, a new advertising analysis shows. Between July 1 and Sept. 16, Americans for Prosperity led all advertising, running more than 3,200 spots to slam the law, according to a tally of advertising by Kantar Media. That’s four times the number of ads placed in the same period by the U.S. Department of Health and Human Services, charged with implementing the law, Kantar’s estimates show. “Opponents have turned this into their primary club in their campaign to batter the president,” said Elizabeth Wilnervice president of Kantar’s Campaign Media Analysis Group.
For the original version including any supplementary images or video, visit http://www.usatoday.com/story/news/politics/2013/09/19/affordable-care-act-advertising-exchanges-health-care-president-obama-americans-for-prosperity-koch-brothers/2833979/
Koch-backed group launches new attack on health care law
On paper, Zoetis makes a lot of sense as an investment with more people than ever owning pets and the cost of animal health care rising in accord with human health care costs. Deep down, though, I sure hope Zoetis has a dividend increase in its cards. Currently, Zoetis is paying out only 19% of its projected 2013 EPS, which is a far cry from what its former parent, Pfizer, typically pays out. R&D expenses do act as somewhat of a constraint on cash flow, but I nonetheless see no reason why Zoetis couldn’t pay out at least $0.40-$0.45 on an annualized basis. Perrigo (NYSE: PRGO ) — 0.29% yield Last, but certainly not least is branded drug and over-the-counter drugmaker Perrigo, which, like Thermo Fisher, is in the midst of a sizable buyout.
For the original version including any supplementary images or video, visit http://www.fool.com/investing/general/2013/09/20/5-health-care-companies-that-should-raise-their-di.aspx